Fthr re Agreement

Sun Life Fin.Services of Canada Inc 27 December 2001 SUN LIFE FINANCIAL SERVICES OF CANADA INC. MATERIAL CHANGE REPORT ITEM 1 Reporting Issuer Sun Life Financial Services of Canada Inc., 150 King Street West, Suite 1400, Toronto, Ontario M5H 1J9 ITEM 2 Date of Material Change December 17, 2001 ITEM 3 Summary of Material Change Sun Life Financial Services of Canada Inc. ('Sun Life Financial') and Clarica Life Insurance Company ('Clarica') announced on December 17, 2001 a definitive agreement to combine operations on their shared vision of a world-class international financial services institution headquartered in Canada. Pursuant to the proposed transaction, Clarica will become a wholly-owned subsidiary of Sun Life Financial, maintaining the Clarica name. The combined Canadian operations of Clarica and Sun Life Financial will be based in Waterloo. The board of directors of Clarica will recommend the acceptance of the proposed transaction to Clarica's shareholders and voting policyholders. ITEM 4 Full Description of Material Change General On December 17, 2001 Clarica and Sun Life Financial entered into a definitive agreement (the 'Transaction Agreement') pursuant to which Sun Life Financial will acquire all of the outstanding common shares of Clarica ('Clarica Shares') through a capital reorganization of Clarica and Clarica shareholders will receive 1.5135 common shares in the capital of Sun Life Financial ('Sun Life Financial Shares') for each Clarica Share held (the 'Transaction'). The completion of the Transaction is subject to the satisfaction or waiver of certain conditions, including: * the approval of the Transaction by at least two-thirds of the votes cast at the Special Meeting referred to below by Clarica shareholders, voting separately as a class, and by at least two- thirds of Clarica's shareholders and voting policyholders, voting together; * the approval of the Transaction by, among others, the Minister of Finance (Canada) and the Superintendent of Financial Institutions (Canada); and * the receipt of approval or expiration or termination of waiting periods under Canadian and United States competition or antitrust laws. Clarica's shareholders and voting policyholders will be asked to consider and, if deemed advisable, approve the Transaction at a special meeting (the 'Special Meeting') which is expected to be held on or about March 1, 2002. If the Transaction is completed, the Clarica shareholders will own, in the aggregate, approximately 32% of the outstanding Sun Life Financial Shares and Sun Life Financial will own all of the outstanding Clarica Shares. The timing of completion of the Transaction will depend upon, among other things, the timing of the receipt of all required regulatory approvals, and is currently anticipated to close in the second quarter of 2002. Certain Terms of the Transaction Agreement Non-Solicitation The Transaction Agreement provides that, except as contemplated below, Clarica and its representatives will not: * solicit, initiate or encourage any inquiry or the making of any proposal to Clarica or its shareholders or policyholders from any person which constitutes, or may reasonably be expected to lead to, in one transaction or a series of transactions, an Alternative Proposal (which is defined, generally, as any of the following or an announcement of its intention to do any of the following: any merger, amalgamation, arrangement, share exchange, take-over bid, recapitalization, consolidation or business combination involving Clarica or any of its material subsidiaries; any acquisition of assets representing 30% or more of the book value (on a consolidated basis) of the assets of Clarica and its subsidiaries, taken as a whole; any acquisition of beneficial ownership of 30% or more of the Clarica Shares; any reinsurance arrangement outside the ordinary course of business involving a substantial part of the insurance liabilities of Clarica; or any material acquisition by Clarica of any assets or securities of another person); * enter into or participate in or continue any discussions or negotiations regarding, agree to or endorse or recommend, or enter into or propose to enter into any agreement, arrangement or understanding in relation to, an Alternative Proposal; or * furnish to any person any information with respect to the business, properties, operations, prospects or condition (financial or otherwise) of Clarica or any of its subsidiaries in circumstances under which it knows, or it ought reasonably to know, that such information will be used by the recipient in connection with, or in order to make or evaluate making, an Alternative Proposal. Clarica's Ability to Respond to Superior Proposal Notwithstanding, the restrictions described above, the board of directors of Clarica may, at any time before the Special Meeting, consider, participate in discussions or negotiations with, or provide information to, any person who has delivered to Clarica a bona fide written Alternative Proposal (with respect to which Clarica has not breached its non-solicitation covenant) provided that Clarica's board of directors, after consultation with its financial and legal advisors, has determined that it is necessary for the directors to take that action in order to discharge properly their fiduciary duties under the Insurance Companies Act (Canada) (the 'ICA') and that such Alternative Proposal is or, if consummated in accordance with its terms, would reasonably be expected to be a Superior Proposal. A 'Superior Proposal' is defined in the Transaction Agreement as an Alternative Proposal that (i) if completed in accordance with its terms, would result in or would reasonably be expected to result in a transaction more favourable to Clarica and its subsidiaries than the Transaction and (ii) is reasonably capable of completion without undue delay having regard to the nature, scope and size of Clarica and its business and the regulatory environment in which it and its subsidiaries operate. Certain Notices to Sun Life Financial Clarica has agreed to notify Sun Life Financial as soon as possible of any bonafide written Alternative Proposal of which Clarica's senior management or board of directors becomes aware, or any request for non-public information in connection with an Alternative Proposal or for access to Clarica's properties, books or records by any person that advises that it is considering making, or has made, an Alternative Proposal. Clarica may provide a person who proposes a bona fide written Alternative Proposal with access to non-public information if the Clarica board of directors determines that such Alternative Proposal is a Superior Proposal, and such person has entered into a confidentiality agreement with Clarica substantially similar to the confidentiality agreement entered into by Clarica and Sun Life . Sun Life Financial's Opportunity to Match Clarica may accept, approve, recommend or enter into an agreement, arrangement or understanding in respect of an Alternative Proposal on the basis that it constitutes a Superior Proposal, provided that: * it gives prompt notice to Sun Life Financial that it proposes to do so; * after consultation with its financial and legal advisors, Clarica's board of directors determines that it would be necessary for the directors to take that action in order to discharge properly their fiduciary duties under the ICA; * it provides to Sun Life Financial a copy of the agreement relating to the Alternative Proposal, if any; and * it provides Sun Life Financial with the opportunity, for a period of five business days from the later of (i) the date Clarica notifies Sun Life Financial of any bonafide written Alternative Proposal of which Clarica's senior management or board of directors has become aware, or any request for non-public information relating to Clarica or any of its subsidiaries in connection with an Alternative Proposal, and (ii) the date that Clarica notifies Sun Life Financial that it proposes to accept, approve, recommend or enter into an agreement in respect of an Alternative Proposal on the basis that it constitutes a Superior Proposal, to negotiate to amend the Transaction Agreement and the terms of the Transaction to provide for terms that to Clarica and the Clarica shareholders are (in the good faith determination of the board of directors of Clarica) as favourable as, or superior to, the terms of the Superior Proposal. If at any time during such five business day period Sun Life Financial elects to make a proposal that, in the good faith belief of the directors of Sun Life Financial, provides for terms that to Clarica and the Clarica shareholders are as favourable as, or superior to, the terms of the Superior Proposal and delivers to Clarica an executed amendment to the Transaction Agreement reflecting the new proposal, the board of directors of Clarica will be required to: * call and hold a meeting of Clarica's board of directors (or the appropriate committee thereof) to consider Sun Life Financial's proposal within 48 hours after receipt of such proposal; * in good faith consider such proposal and permit Sun Life Financial and its representatives to make a presentation to the meeting in respect of the relative merits of Sun Life Financial's proposal and the Superior Proposal (but not otherwise to attend or participate in the meeting or the deliberation of the board of directors of Clarica); and * not later than the date the meeting of Clarica's board of directors is required to be held as set forth above, determine and advise Sun Life Financial as to whether Clarica's board of directors has determined that Sun Life Financial's proposal provides for terms that to Clarica and its shareholders are as favourable as, or superior to, the terms of the Superior Proposal. In the event that Clarica's board of directors determines that the Sun Life Financial proposal provides for terms that to Clarica and its shareholders are as favourable as, or superior to, the terms of the Superior Proposal, it will cause Clarica immediately thereafter to execute the amendment to the Transaction Agreement delivered by Sun Life Financial and not take any actions in furtherance or support of the Superior Proposal. If, however, Clarica's board of directors continues to believe, in good faith, and after consultation with its financial advisors and outside counsel, that the Superior Proposal continues to be a Superior Proposal, and therefore rejects Sun Life Financial's amended proposal, then, subject to payment of the Termination Fee (described below) to Sun Life Financial, Clarica may terminate the Transaction Agreement. Clarica will not have any of the rights described above after the Special Meeting if the Transaction is approved at the Special Meeting. Termination The Transaction Agreement my be terminated at any time prior to closing (even if the Clarica shareholders and policyholders have approved the Transaction at the Special Meeting); (a) by mutual agreement of Sun Life Financial and Clarica; (b) by Sun Life Financial or Clarica if the Transaction or any part of it is illegal or otherwise prohibited by law, or if any final and non-appealable judgment, injunction, order or decree of a court or regulatory authority prohibiting Sun Life Financial or Clarica from proceeding with or completing the Transaction or any part of it is entered; (c) by Sun Life Financial or Clarica if any of the conditions to the closing of the Transaction relating to the receipt of all required regulatory approvals becomes incapable of satisfaction; (d) by Sun Life Financial or Clarica if the closing does not occur on or prior to September 30, 2002; subject to the extension of such date to December 31, 2002 in certain circumstances in the event that the delay in closing is the result of an injunction or order made by a court or regulatory authority or the parties not having obtained any required regulatory approval; (e) by Sun Life Financial if: (i) Clarica's board of directors fails to recommend or withdraws, modifies or changes its approval or recommendation of the Transaction Agreement or the Transaction in a manner adverse to Sun Life Financial; (ii) following the announcement of an Alternative Proposal, Clarica's board of directors fails to affirm its approval or recommendation of the Transaction Agreement or the Transaction within five business days after any written request to do so from Sun Life Financial; (iii) Clarica has breached its non-solicitation obligations; or (iv) Clarica's board of directors accepts, approves, recommends or enters into an agreement (other than a confidentiality agreement) with any person with respect to a Superior Proposal; (f) by either Sun Life Financial or Clarica, if at the Special Meeting the requisite votes of the shareholders and voting policyholders to approve the Transaction, are not obtained; (g) by Clarica where Clarica has delivered to Sun Life Financial notice that it intends to accept, recommend, approve or enter into an agreement in respect of an Alternative Proposal on the basis that it constitutes a Superior Proposal and Sun Life Financial has failed to amend the Transaction Agreement to provide for terms that, in the determination of Clarica's board of directors, are as favourable as, or superior to, the terms of the Superior Proposal; (h) by Sun Life Financial, if Clarica has breached any of its representations, warranties, agreements, covenants or obligations in the Transaction Agreement in any material respect and such breach is not curable or if curable is not cured within 15 days after notice; (i) by Clarica, if Sun Life Financial has breached any of its representations, warranties, agreements, covenants or obligations in the Transaction Agreement in any material respect and such breach is not curable or if curable is not cured within 15 days after notice; (j) by Sun Life Financial, if there has been since the date of the Transaction Agreement (or, if there exists or has previously occurred, there has been disclosed, generally or to Sun Life Financial), any change, event, occurrence or development that would reasonably be expected to have a material adverse effect on Clarica or that would materially and adversely affect the ability of Clarica to perform its obligations under the Transaction Agreement; or (k) by Clarica, if there has been since the date of the Transaction Agreement (or, if there exists or has previously occurred, there has been disclosed, generally or to Clarica), any change, event, occurrence or development that would reasonably be expected to have a material adverse effect on Sun Life Financial or that would materially and adversely affect the ability of Sun Life Financial to perform its obligations under the Transaction Agreement. Termination Fee and Expense Reimbursement Clarica will be required to pay a termination fee of $310 million (the 'Termination Fee') or $50 million in respect of the reimbursement of expenses (the 'Expense Reimbursement Amount') to Sun Life Financial in the event that: * the Transaction Agreement is terminated by Sun Life Financial in the circumstances described in paragraph (e) under '- Termination' above, in which case the Termination Fee must be paid to Sun Life Financial within three business days following such termination; * (i) prior to the date of the Special Meeting a bona fide Alternative Proposal has been made, or any proposal or expression of interest by a third party regarding an Alternative Proposal has been publicly disclosed or announced, (ii) the Transaction Agreement is terminated by either party because the Transaction is not approved by shareholders and policyholders at the Special Meeting and (iii) either (A) the Alternative Proposal referred to in (i) above is subsequently completed or (B) within 12 months after the date of the Special Meeting another bonafide Alternative Proposal is made or a proposal or expression of interest by a third party regarding an Alternative Proposal is publicly disclosed or announced and such Alternative Proposal is subsequently completed, in which case the Termination Fee must be paid to Sun Life Financial immediately prior to the completion of either such Alternative Proposal; * the Transaction Agreement is terminated by Sun Life Financial (i) as the result of a breach by Clarica of the Transaction Agreement as described in paragraph (h) under '- Termination' above and prior to such termination a bona fide Alternative Proposal has not been made, and at such time no proposal or expression of interest by a third party regarding an Alternative Proposal has been publicly disclosed or announced, or (ii) as 'the result of a material adverse change with respect to Clarica described in paragraph (j) under '- Termination' above, in which case the Expense Reimbursement Amount must be paid to Sun Life Financial within three business days following notice of such termination; * the Transaction Agreement is terminated by Sun Life Financial as the result of a breach by Clarica of the Transaction Agreement as described in paragraph (h) under '-Termination' above and prior to such termination a bona fide Alternative Proposal has been made, or any proposal or expression of interest by a third party regarding an Alternative Proposal has been publicly disclosed or announced, or (ii) as the result of a material adverse change with respect to Clarica described in paragraph (j) under '--Termination' above, in which case the Expense Reimbursement Amount must be paid to Sun Life Financial within three Business Days following such termination; * the Transaction Agreement is terminated by Sun Life Financial as the result of a breach by Clarica of the Transaction Agreement as described in paragraph (h) under '--Termination' above and prior to such termination a bona fide Alternative Proposal has been made, or any proposal or expression of interest by a third party regarding an Alternative Proposal has been publicly disclosed or announced, in which case (i) the Expense Reimbursement Amount must be paid to Sun Life Financial within three Business Days following such termination and (ii) if at any time within 12 months following the date of such termination, Clarica enters into any agreement for an Alternative Proposal or consummates a transaction that constitutes an Alternative Proposal, the Termination Fee (less the Expense Reimbursement Amount paid under clause (i) must be paid to Sun Life Financial immediately prior to the completion of either such Alternative Proposal; and * the Transaction Agreement is terminated by Clarica as the result of Sun Life Financial having failed to match a Superior Proposal as described in paragraph (g) under '- Termination', in which case the Termination Fee must be paid to Sun Life Financial prior to such termination. Sun Life Financial will be required to pay the Expense Reimbursement Amount to Clarica in the event that the Transaction Agreement is terminated by Clarica as the result of a breach by Sun Life Financial of the Transaction Agreement as described in paragraph (i) under '- Termination' above or as the result of a material adverse change with respect to Sun Life Financial described in paragraph (k) under 'Termination' above, in which case the Expense Reimbursement Amount must be paid to Clarica within three business days following notice of such termination. ITEM 5. Reliance on Section Not applicable. ITEM 6. Omitted Information Not applicable. ITEM 7. Contact Officer Thomas A. Bogart, Executive Vice-President and Chief Legal Officer, Sun Life Financial Services of Canada Inc. Telephone: (416)979-4024 Fax: (416) 979-3209 ITEM 8. Statement of Senior Officer The foregoing accurately discloses the material change referred to herein. SIGNED this 27th day of December, 2001 at Toronto, Ontario Per:'Thomas A. Bogart' Thomas A. Bogart Executive Vice-president and Chief Legal Officer
UK 100

Latest directors dealings